---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-024465"
form_type: "8-K"
ticker: "PMI"
cik: "0002030617"
company_name: "Picard Medical, Inc."
filed_at: "2026-07-27T13:12:15+00:00"
generated_at: "2026-07-27T13:13:05.852159+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# NYSE American accepts Picard Medical's compliance plan; listing continues through Nov 2027

## Summary
- NYSE American accepted compliance plan under Sections 1003(a)(i) and (ii) due to low equity and losses.
- Company may continue listing on NYSE American under symbol PMI while executing the plan.
- Compliance period through November 8, 2027, subject to quarterly review by NYSE American.
- Company must achieve milestones set forth in the compliance plan to regain full compliance.
- Interim CEO Richard Fang cites progress on Emperor Total Artificial Heart and financial position.

## SEC filing metadata
- accession: 0001437749-26-024465
- form_type: 8-K
- ticker: PMI
- cik: 0002030617
- company_name: Picard Medical, Inc.
- filed_at: 2026-07-27T13:12:15+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2030617/000143774926024465/0001437749-26-024465-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2030617/000143774926024465/pmi20260722_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-024465
- JSON: https://secwatch.observer/filing/0001437749-26-024465.json
- Plain text: https://secwatch.observer/filing/0001437749-26-024465.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.